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Abstract
Significance: Optical coherence tomography (OCT) provides cross-sectional and volumetric
images of backscattering from biological tissue that reveal the tissue morphology. The strength
of the scattering, characterized by an attenuation coefficient, represents an alternative and com-
plementary tissue optical property, which can be characterized by parametric imaging of the
OCT attenuation coefficient. Over the last 15 years, a multitude of studies have been reported
seeking to advance methods to determine the OCT attenuation coefficient and developing them
toward clinical applications.
Aim: Our review provides an overview of the main models and methods, their assumptions
and applicability, together with a survey of preclinical and clinical demonstrations and their
translation potential.
Results: The use of the attenuation coefficient, particularly when presented in the form of para-
metric en face images, is shown to be applicable in various medical fields. Most studies show the
promise of the OCT attenuation coefficient in differentiating between tissues of clinical interest
but vary widely in approach.
Conclusions: As a future step, a consensus on the model and method used for the determination
of the attenuation coefficient is an important precursor to large-scale studies. With our review,
we hope to provide a basis for discussion toward establishing this consensus.
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1 Introduction
Optical coherence tomography (OCT) discriminates the backscattered light from a tissue sam-
ple based on the path length that the light has traveled, being exquisitely sensitive to light that
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has undergone one or a few scattering events.1 This extraordinary ability is achieved largely
through coherence gating, augmented by confocal gating, and simultaneously rejects out-of-
focus light and imposes a selected path length. Depth-resolved images of this backscattering in
tissue can be obtained, ex vivo and in vivo, with a resolution commonly in the range 5 to 15 μm,
although sub-1-μm resolution has been demonstrated.2 Currently, OCT is primarily used to
visualize the morphology of tissue, which can be used to differentiate pathology in some
circumstances.3 There is further clinical value, in addition to visualization, to use OCT to differ-
entiate pathology based on the altered structure and organization not readily visible with con-
ventional clinically available imaging techniques. The structure and organization of a tissue are
reflected in its optical properties,4,5 and perhaps the most accessible such property in OCT is the
attenuation coefficient, describing the extinction with depth of the detected OCT signal due to
absorption and scattering. To measure the OCT attenuation coefficient (μOCT) and obtain diag-
nostic information from this measure, a model of the OCT signal and a model correlating μOCT
to the optical properties (absorption and scattering coefficient; Sec. 2), and ultimately to the
tissue structure, must be developed (Sec. 3).6–8 Recently, with the common advent of volumetric
OCT imaging, it has become feasible to produce two-dimensional (2-D) en face, and even
three-dimensional (3-D) depth-resolved maps of μOCT, representing an example of the general
class of parametric imaging.9 Consequently, this topic has generated increased interest in the
literature.10–12
The onset and advance of diseases or injury are often accompanied by structural and func-
tional changes in tissues. These changes can range from easily visible scars, to increased blood
perfusion during inflammation (which may be observed as redness), to an increase of intra-
cellular mitochondrial proliferation during the early stages of cancer development. A major dif-
ference lies in the length scales at which these changes occur. Whereas scars in skin are readily
observed by visual inspection, the assessment of subcellular changes requires higher sensitivity
and resolution. With such techniques for in vivo assessment not widely available, the current
standard for early diagnosis is the excision of small tissue sections followed by histochemical
staining and microscopic evaluation by a pathologist. For many applications on all length scales,
OCT may provide a viable alternative that mitigates the drawbacks of histopathology: be it in
terms of patient well-being, by enabling less invasive and more immediate diagnostic proce-
dures, or in terms of economic cost, by reducing the number of unnecessary pathological
assessments.
First and foremost, OCT provides high-resolution 3-D imaging of tissue structures. For
example, OCT can quantify epithelial layer thickening (up to the point of disappearance of tissue
layering) that is associated with increasing stage (growth) of cancer. Second, subresolution
changes in tissue morphology during onset and progression of disease lead to changes in optical
absorption and scattering properties of the tissue that can be assessed through quantitative meas-
urement of the OCT signal decay with depth. These subresolution changes are not directly avail-
able to imaging, leading to poor contrasts in the tissue structures provided by conventional OCT.
For tissue characterization relevant to such small-scale changes, quantitative measurement of the
tissue attenuation forms an important complement to conventional OCT (Sec. 4).
Preclinical and clinical studies in a wide variety of medical fields, including dermatology and
skin, in general, cardiology, and urology, have shown promising results on the use of μOCT for
tissue characterization.9,13–19 The associated literature presents multiple models and methods to
determine μOCT and to relate it to tissue optical properties. To advance the application of μOCT for
tissue characterization, a standardized and validated approach to obtain reliable values of μOCT,
and to deal with issues such as tissue heterogeneity and the length scales on which this occurs, is
needed. The aim of this review, then, is to present an overview of the models, methods, and
applications of parametric imaging of attenuation by OCT and to discuss issues in the determi-
nation of μOCT with the ultimate goal of establishing a unified basis for future clinical research on
using μOCT. To this end, the review is divided from here on into four sections. In Sec. 2, the
relationship between tissue optical properties and the OCT attenuation coefficient is discussed.
In Sec. 3, commonly used models for the OCT signal are summarized. In Sec. 4, an overview
of potential preclinical applications and clinical translation of μOCT is given, accompanied with
a summary of the reported μOCT values. Finally, in Sec. 5, the limitations of the models and
methods, together with clinical challenges and future perspectives, are discussed.
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2 Tissue Optical Properties
Absorption and scattering, the two components of attenuation, fundamentally arise from (spatial
variations in) the complex refractive index of tissue mðrÞ ¼ nðrÞ þ iκðrÞ. The local absorption
coefficient is directly proportional to the imaginary part of the complex refractive index through
μaðrÞ ¼ 2kκðrÞ, where k ¼ 2π∕λ is the wavenumber; and λ is the wavelength. Gradients in the
real refractive index nðrÞ redirect light by refraction on a microscopic scale and, thus, redistribute
its propagation direction, determining the local scattering coefficient and phase function.
Absorption directly reduces the light intensity by converting it into other forms of energy.
It is parameterized by the absorption coefficient μa, which, for a homogeneous distribution of
absorbers, is the product of the density and absorption cross section of the absorbing particles.
The wavelength-dependent absorption spectrum of tissue is determined by the presence of vari-
ous chromophores in tissue, where hemoglobin, melanin, and water are dominant. However,
in order to achieve maximum imaging depths, OCT generally operates in near-infrared spectral
regions where the absorption by these chromophores is low. For this reason, μOCT is dominated
by attenuation due to scattering at the commonly used wavelengths (800 and 1300 nm as shown
in Sec. 4) for OCT attenuation coefficient analysis. Previous studies have shown approximately
10 times higher scattering than absorption in the near-infrared ranges typically used for OCT.20,21
Thus, the effects of absorption, which are notably present in OCT using visible wavelengths,22
spectroscopic OCT,23,24 and low-coherence spectroscopy,25 do not play a role in the research on
the OCT attenuation coefficient reviewed here and will not be discussed further.
Analogous to absorption, the scattering strength is parameterized by the scattering coefficient
μs, which, for low particle densities, is the product of the particle density and scattering cross
section. The scattering coefficient depends both on the wavelength and the scatterer dimensions.
In elastic scattering, which is relevant for OCT, no energy conversion takes place, but scattered
light is spatially redirected and so the intensity of an incident wave is diminished. The scattering
phase function describes this process of angular redistribution of energy. It is often convenient to
parameterize the phase function in terms of Legendre moments, the first of which is called the
scattering anisotropy g. It physically corresponds to the average cosine of the scattering angle
(g ¼ 1, thus, implies all light is scattered in the forward direction). The phase function and scat-
tering anisotropy are dependent on wavelength and scatterer dimensions as well. In general, large
particles (with respect to wavelength) will scatter more strongly in the forward direction.
The absorption and scattering coefficients are formally defined in terms of interaction prob-
ability per unit path length. Their sum is the attenuation coefficient, μt ¼ μa þ μs, which
describes the decay of the incident light due to the tissue optical properties. In contrast, the
OCT attenuation coefficient, μOCT, parameterizes the loss of OCT signal with depth, caused
by absorption and scattering, when this loss is modeled as a single exponential decay in the
form of Beer’s law, ∝ expð−μOCTzÞ. This simple parameterization absorbs most of the complex-
ity, but sacrifices a direct relation to tissue optical properties (e.g., anisotropy, g; μa; μs) for the
sake of robustness and uniqueness of the measurement. In addition, OCT system properties, such
as the confocal point spread function (CPSF) and sensitivity roll-off (for Fourier-domain OCT
systems) also cause a depth-dependent response. We will discuss in Sec. 3 how various signal
models summarize tissue optical properties in a single parameter, μOCT. Modeling the connec-
tion between tissue structure, optical properties, and measured quantities remains a formidable
challenge, which we will not resolve in this review. Most research discussed here will correlate
tissue type and structure (through the gold standard of histopathology) to the measured OCT
attenuation coefficient.
3 Models of the OCT Signal
In OCT, the field in the sample arm results from electromagnetic scattering of broadband light in
tissue, a complex dielectric. Because of the variations of the complex refractive index mðrÞ in
tissue, and because of the many length scales at which this variability contributes to the scattered
field,26 it is generally impossible and almost certainly impractical to strive for an exact inversion
of Maxwell’s equations, solving them for mðrÞ. As the field propagates, energy is removed
from the incident beam while backward scattering feeds the returning field, as shown in Fig. 1;
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the attenuation coefficient μOCT is a single parameter to quantify the strength of this interaction
of light and tissue. Extraction of the μOCT from the acquired data requires a quantitative model
for the OCT signal that can be applied to the measurement.
A number of different models have been proposed to describe the OCT signal. In order of
increasing complexity and the number of free parameters, these models may be summarized as
“single-scattering,” “multiple-scattering” (including stochastic methods such as Monte Carlo),
and “full electromagnetic wave modeling.” Among them, the single-scattering model (Sec. 3.1)
is most commonly used, whereas others (Sec. 3.2) have been applied to a smaller number of
samples or are still in the early stages of development. All of these models need to be calibrated
with system-specific parameters for practical applications.
3.1 Single-Scattering Model
The simplest models for the OCT signal rely on the first-order Born approximation; they
assume that the incident beam propagates in the forward direction, attenuated by absorption
and scattering according to Beer’s law, until a backward scattering event reflects the light
back toward the source. Any detected light from the sample arm has interacted with the sample
only in a single-scattering event. For plane wave illumination, homogeneous optical scattering,
and in the absence of noise and any instrumental effects, the mean OCT signal may be written
as28
EQ-TARGET;temp:intralink-;e001;116;315hAðzÞi ∝ A0 expð−μOCT · zÞ; (1)
where AðzÞ is the OCT signal amplitude, A0 is the amplitude at z ¼ 0 (the tissue boundary), and
μOCT is the attenuation coefficient. Brackets h·i denote the average over different spatial real-
izations of the complex refractive index mðrÞ.
One subtlety may be noted: in Beer’s law, the absorption coefficient μa and scattering coef-
ficient μs govern the decay of the intensity IðzÞ, not of the field amplitude described in Eq. (1).
The attenuating medium is, however, traversed twice since the signal travels from the source to a
depth z and then back toward the detector, and the path length is equal to 2z. Thus, the detected
signal is hIðzÞi ¼ I0 expð−2μOCTzÞ but since in the absence of noise hAðzÞi ∝
ffiffiffiffiffiffiffiffiffiffiffiffihIðzÞip , the
factor of 2 in the exponent is canceled in Eq. (1). In Fourier-domain OCT, the spatial signal
is obtained through Fourier transform. For optimum processing speed, in most applications, the
fast-Fourier transform (FFT) algorithm is used, after resampling of the spectral interferogram
SðkÞ onto a uniform wavenumber (k) basis. The outcome of this procedure is the OCT amplitude
versus depth as given by Eq. (1). Alternatively, the power spectral density or jFFTj2 may be used,
which would yield the OCT intensity versus depth.
The models discussed here aim to quantitatively describe the OCT signal in terms of the
tissue attenuation, μt ¼ μa þ μs, a number that is based on the assumption of single scattering.
However, even in the presence of multiple scattering (Sec. 3.2), the part of the signal decay
caused by absorption and scattering is often adequately modeled as a single exponential decay,
Fig. 1 Propagation of a focused OCT beam and ray representation of scattering in the sample.27
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albeit with a decay coefficient μOCT < μt (because multiple scattering causes more light to be
detected than expected based on the single-scattering model). Without additional controlled
experiments, for instance at different scatterer concentrations, it may not be possible to say with
certainty that a measurement was done in the single-scattering regime. Thus, the adoption of
μOCT allows us to describe tissue attenuation as measured by OCT as an effective parameter
that does not require an estimate of the relative weight of single and multiple scattering
contributions.
3.1.1 Practical application of the single-exponential decay model
Already when introducing this model for the OCT signal, Schmitt et al.1 realized that Eq. (1)
needs to be modified for finite numerical aperture (NA). They introduced a correction for the
divergence of the sample beam and used this to quantify the attenuation and backscattering coef-
ficients of weakly scattering microsphere suspensions. In addition, for Fourier-domain OCT, the
system sensitivity decreases with depth from the zero-delay point depending on the sampling of
the wavenumber axis. A constant factor α < 1 describes the coupling efficiency of the input
amplitude A0 to the OCT system, which is redirected back toward the detector with a
power-backscattering coefficient μb;NA. With these factors taken into account, including noise,
Eq. (1) becomes
EQ-TARGET;temp:intralink-;e002;116;506hAðzÞi ¼ α · A0 · tðz − zfÞ · hðz − z0Þ · ffiffiffiffiffiffiffiffiffiffiμb;NAp expð−μOCTzÞ þ noise: (2)
Here, the backscattering coefficient, μb;NA, depends on the NA of the system since that deter-
mines the collection angle. Coordinate z is the geometrical distance from the tissue boundary,
into the tissue. The factor tðz − zfÞ is the CPSF, which is derived from the beam divergence
correction factor1 to yield the following expression for a Gaussian beam:29
EQ-TARGET;temp:intralink-;e003;116;425 ðz − zfÞ ¼
1ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
z−zf
2nzR

2 þ 1
r ; (3)
where zf is the geometrical depth location of the focus relative to the tissue boundary, zR is the
Rayleigh length of the Gaussian beam incident on the sample, and n is the average refractive
index of the medium along the beam. The factor of 2 in 2nzR takes into account the increase in zR
for a diffuse reflector compared to specular reflector.29,30
The sensitivity roll-off of the system is described by hðz − z0Þ, where z0 is the distance
between the zero-delay position of the interferometer and the tissue boundary. The finite sam-
pling density of the interference fringes and the finite resolution of the frequency scan together
reduce the signal far from the zero-delay position. The former derives from the detector pixel
width in spectral-domain OCT, and from the detector integration time in swept-source OCT, and
is described by a sinc function. The latter factor is the spectrometer optical resolution in spectral-
domain OCT (spot size in the spectrometer), or the instantaneous linewidth in swept-source
OCT, and can be modeled as a Gaussian function. Combining resolution and sampling depend-
encies, hðz − z0Þ is expressed as31
EQ-TARGET;temp:intralink-;e004;116;210hðz − z0Þ ¼
sinc

πðz − z0Þ
2zD
 exp

−
π2s2
16 lnð2Þ
ðz − z0Þ
zD

2
	
: (4)
Here, zD ¼ λ2∕4nΔλ is the maximum imaging depth of a system with sampling pitch Δλ at
center wavelength λ and at average group refractive index n of the medium, measured with
respect to zero delay, and s is the ratio of spectral resolution to the sampling pitch.32,33
Since spectral resolution and sampling pitch are usually finer in swept source systems, hðz − z0Þ
is flatter for swept-source systems compared to spectral-domain systems, resulting in a higher
signal-to-noise ratio (SNR) at greater depths. Examples of the confocal PSF and sensitivity
roll-off from a swept-source OCT scanner are shown in Fig. 2.
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Measurement of the attenuation coefficient requires quantitative modeling of the instrumental
response function, CPSF, and sensitivity roll-off, according to Eqs. (3) and (4). If the detailed
optical design parameters (specifically, the focal depth zf and Rayleigh length zR of the imaging
optics, and resolution and sampling of the frequency scan) are unknown, these functions can be
experimentally determined from the measurement of a reflector versus depth, and a knife-edge
measurement may be used to yield the Gaussian beam parameters.32,34 Alternatively, a very
weakly scattering calibration sample may be used to determine the CPSF and sensitivity
roll-off function by substituting Eqs. (3) and (4) into Eq. (2) and then fitting it to the OCT signal
amplitude, with s, zf, and zR as free parameters and setting μOCT ¼ 0. Another approach based
on an OCT measurement of a very weakly scattering calibration sample is by first subtracting the
mean noise level (typically estimated in a deep region with only noise present) included in
Eq. (2) and then assuming μOCT ¼ 0 so that the signal of the calibration sample only comprises
α · A0 · tðz − zfÞ · hðz − z0Þ · ffiffiffiffiffiffiffiffiffiffiμb;NAp . The signal from a highly scattering sample, after remov-
ing the noise level similarly, can then be divided by the calibration signal, canceling the
α · A0 · tðz − zfÞ · hðz − z0Þ, directly yielding the data for attenuation analysis.17 For example,
Gong et al.35 used a solution of 0.5-μm-diameter polystyrene microspheres with an estimated
attenuation coefficient of 0.1 mm−1. As the CPSF is influenced by the refractive index of the
sample, it is desirable for the calibration sample to have a refractive index similar to the samples
to be studied.
3.1.2 Fitting method
Nonlinear least squares curve fitting, preferably applied to the amplitude data, is the most
straightforward approach for obtaining μOCT using the single-scattering model: by varying the
free parameters A0 and μOCT while fixing the other parameters to optimize the fit of Eq. (2). Note
that if the noise is not corrected or cannot be ignored, squaring the OCT amplitude induces cross
terms that can influence the fitted attenuation coefficient. Alternatively, a linear fit to the log-
arithm of the OCT data can be performed after subtraction of the logarithm of the CPSF,
sensitivity roll-off, and noise from the data. Any fit method requires a region of interest (ROI)
or window selection of axial fitting range (AFR), as shown in Fig. 3, which can be done man-
ually or automatically. We note, however, that for most applications, manual selection would be
too labor-intensive in any eventual routine use. The analysis is performed under the assumption
that the tissue optical properties are homogeneous within the window, so the axial resolution of
the attenuation measurement is limited by this window size (i.e., AFR). This assumption may be
verified by uncertainty and goodness-of-fit estimates (e.g., R2 and residue) used to assess fit
quality. Challenges within the fitting method are the influence of speckle on the goodness of
Fig. 2 Simulated average A-scan hAðzÞi according to Eq. (2) (black curve) and the contribution
of the individual terms, including single exponential decay (red dash), CPSF tðzÞ (blue dash),
and sensitivity roll-off hðzÞ (green dash). Parameters for the simulation are: z0 ¼ 0.25 mm;
μs ¼ 5 mm−1; refractive index n ¼ 1.4; noise floor at −80 dB; Rayleigh length zR ¼ 100 μm; focus
location zf ¼ 1 mm; center wavelength and spectral sampling increment are λ ¼ 1300 nm and
Δλ ¼ 0.1 nm, respectively, giving a maximum imaging depth of zD ¼ 3 mm; s ¼ 2.
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the fit, AFR selection, and noise-level selection. Lateral and/or axial averaging can reduce the
variability due to speckle in the A-scan data prior to fitting. By averaging, the resolution of the
measured μOCT is decreased, the suitability of which must be considered against the needs of
the application.
Performing linear fits on logarithmically compressed data is computationally more efficient,
but the procedure is sensitive to underestimation of large attenuation coefficients in the presence
of noise, depending on the window length. Yuan et al.36 showed that values of μOCT of 5 and
7 mm−1 were underestimated in linear fits for ROIs larger than 800 and 600 μm, respectively.
A shorter window means that stronger attenuation can be characterized without noise compro-
mising the analysis. Low amplitudes at the end (greater z) of the ROI, which are more strongly
affected by noise, have a larger weight in the compressed than in the noncompressed data. This
issue may be readily dealt with by weighting the data point by the SNR, as has been used in
optical coherence elastography.37
The range in which the fit can be considered valid can be assisted by a comparison between
the modeled signal decay within the ROI, compared to the noise level of the OCT system; the
range typically is in the order of a few times the attenuation length (about 4 times in the example
cited above).36 Multiple fits with a small depth variation of the ROI may yield an average and
standard deviation of μOCT; in this way, the influence of the ROI selection on the obtained value
of μOCT can be taken into account.
28 Heterogeneity in the tissue and buildup of multiple scatter-
ing can be mitigated by adaptively choosing a fitting ROI and analyzing each A-scan in sections
leading to 2-D parametric imaging of tissue properties.16 Fitting of very thin tissue layers (e.g.,
retinal layers) or tissue layers close to the surface (e.g., the epidermis) is challenging because
there are insufficient sample points for a reliable fit within a homogeneous layer.38
3.1.3 Depth-resolved method
An interesting depth-resolved method was proposed by Vermeer et al.38 for pixel-by-pixel deter-
mination of μOCT inspired by attenuation compensation in ultrasound data.
39 It does not require
a fit window and, therefore, retains the OCT resolution in the attenuation image. Based on an
integral formulation of the intensity [and not amplitude as in Eq. (1)] in the single-scattering
model, μOCT is calculated based on two main assumptions: (1) all the light is extinguished within
the OCT image depth range; and (2) the backscattered light is a fixed fraction of the attenuation
coefficient, i.e., the ratio of μb;NA and μOCT is constant. Assuming a constant intensity over a
pixel, the attenuation is expressed as
EQ-TARGET;temp:intralink-;e005;116;138μOCT½i ¼
1
2Δ
log


1þ I½iP∞
iþ1 I½i

; (5)
where i is the i’th pixel along an A-scan and I½i is the intensity of the signal at the i’th pixel.
This equation can be simplified by applying a first-order linearization of logð1þ xÞ around
x ¼ 0 to give
Fig. 3 Procedure of fitting to retrieve the attenuation coefficient. One A-scan in (b) is extracted
from an intravascular OCT image in (a) along the red line, speckle smoothed and fitted in
subsequent windows. The retrieved μOCT is plotted as an overlay on the grayscale image in (c).
Colormap: 0 to 12 mm−1.
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EQ-TARGET;temp:intralink-;e006;116;735μOCT½i ≈
I½i
2Δ
P∞
iþ1 I½i
: (6)
It is noteworthy that the validity of the sum to infinity in Eq. (6) requires that the values of the
OCT signal in the last pixels in the image should be negligible, meeting the first assumption
above. In the original formulation38 and subsequent applications40 of the depth-resolved attenu-
ation coefficient analysis, the CPSF and sensitivity roll-off in depth were not taken into account.
Smith et al.41 introduced these corrections, including for noise. The depth-resolved method was
validated on homogeneous and layered phantoms by Vermeer et al.38 and showed promising
results for estimating attenuation coefficients with a higher axial resolution. As pointed out
above, though, the method relies on the assumptions of complete extinction in an A-scan and
a fixed ratio between μOCT and μb;NA. The former becomes more problematic for pixels toward
the end of the A-scan and when prominent multiple-scattering background is present, which can
be eliminated by carefully choosing a cutoff constant.40,42 The latter assumption does not hold in
the case of absorption or for scatterers with a strongly structured angular scattering cross section,
such as Mie scatterers. Since μOCT is directly proportional to I½i in Eq. (6), the analyzed attenu-
ation contains speckle. This artifact may be dealt with by conventional methods such as local
averaging or median filtering, which will then lower the resolution. Validation studies on tissue
are still scarce, so the impact of the assumptions and necessary postprocessing on the accuracy of
the extracted attenuation coefficients, and their utility for tissue classification, is not yet clear.
Alternatively, Yuan et al.36 proposed a distinct frequency-domain method, aided by Fourier
transformation, to extract the attenuation coefficients. The method was compared to the fitting
method, showing robust performance and fast computation. It is a potentially powerful alterna-
tive to the fitting and depth-resolved methods, the merits of which may become clear with wider
adoption in future.
3.2 Multiple Scattering
In addition to singly scattered light, multiply scattered light that matches the detected optical path
length set by the reference delay contributes to the OCT signal.43–46 In highly forward scattering
tissues such as blood, multiple scattering can be expected.47–49 The contribution of multiply
scattered light leads to a lower resolution and introduces a signal additional to that of singly
scattered light. The contribution from multiply scattered light increases for (1) larger depths,50
(2) samples with stronger forward scattering,28 (3) samples with higher scattering coefficients,28
and (4) lower NAs.50
Figure 4 shows the difference in OCT signal between an isotropic and anisotropic (forward
scattering) sample in order to demonstrate the contribution of multiply scattered light. The two
Fig. 4 Average OCT amplitude for samples of pure silica beads in water. The 0.5-μm beads
(black) with scattering coefficient of 5 mm−1 and anisotropy factor of 0.1 and 1.5-μm beads (red)
with scattering coefficient of 5 mm−1 and anisotropy factor of 0.9. OCT data were collected using
a swept-source 1300-nm system with a 150-mm-focal length detection lens.
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samples comprise silica beads with diameter of, respectively, 0.5 (in black as the isotropic sam-
ple) and 1.5 μm (in red as the anisotropic sample). They have the same attenuation coefficient
estimated by Mie simulation and present the same linear decay (i.e., slope) in the logarithmic
OCT signal in the single-scattering regime. Multiple scattering lifts up the linear decay at large
depths with the large particles exhibiting the contribution by multiply scattered light from a
much shallower depth than the small particles and, thus, generating more significant deviation
from the single-scattering model. Faber et al.30 have shown that, for scattering media with μs <
6 mm−1, the single-scattering model-based μOCT gives a good estimate of μs.
51,52 Experiments
on samples with controlled optical properties show that multiple scattering starts to contribute
significantly to the OCT signal for samples with μs > 10 mm−1 or g > 0.8.
28
To date, there are three main approaches to take into account for multiple scattering in
OCT: probabilistically, with Monte Carlo simulations;53,54 and analytically, with the extended
Huygens–Fresnel (EHF) model for OCT45,55,56 or ab initio full-wave simulations based on
Maxwell’s equations.57–59 We briefly discuss each below.
3.2.1 Monte Carlo simulation
Monte Carlo simulation is a probabilistic approach to simulate the scattering trajectory of pho-
tons in the sample. The simulation tracks the trajectory of photons in the sample arm and outputs
the photon count and corresponding path lengths. An assumption for the phase function of the
sample is needed as an input to the simulation, and restrictions on photon count and trajectory
are required to create time-efficient simulations. Multiple studies have been done on Monte-
Carlo-based simulations of the OCT signal.46,60,61 Jacques et al.53 applied Monte Carlo simu-
lation to derive a general equation to correct the OCT attenuation coefficient for the contribution
of multiple scattering to determine tissue optical properties, including μs and g. This approach
was applied in subsequent studies by Levitz et al.54 to study the growth of collagen gels.
In general, Monte Carlo simulations do not model the interference of the reference with the
sample light explicitly. Karamata et al.43,44 combined their analytical model, in which the coher-
ence was taken into account, with Monte Carlo simulations to account for both singly and multi-
ply scattered light. A limitation of Monte Carlo simulations is that the results obtained depend
on the specific chosen input parameters, such as the system-specific optical geometry, and the
phase function, which is generally not well known for tissue and, indeed, unlikely to be constant
across the simulated region.62 Monte Carlo approaches are useful for forward modeling, but their
probabilistic output cannot be straightforwardly inverted for analysis of experimental data.
3.2.2 Extended Huygens–Fresnel model
The EHF model for OCT was introduced by Schmitt and Knüttel45 and elaborated by Thrane
et al.55,56 The model assumes the paraxial approximation [i.e., sinðθÞ ≈ θ, where θ is the angle of
the scattered wavevector relative to the incident wavevector] and the theory is applicable to sam-
ples with g > 0.7. The mean OCT intensity is expressed in three terms: (1) the singly backscat-
tered field, (2) the multiply (forward) scattered field, and (3) the coherent cross-term between
these two fields. The expression for the mean squared OCT amplitude (which is equal to OCT
intensity) is
EQ-TARGET;temp:intralink-;e007;116;204hA2ðzÞi ∝ 1
w2HðzÞ
(
expð−2μszÞ þ
4 expð−μszÞ½1 − expð−μszÞ
1þ w2SðzÞw2HðzÞ
þ ½1 − expð−μszÞ2
w2HðzÞ
w2SðzÞ
)
;
(7)
where
EQ-TARGET;temp:intralink-;e008;116;128w2HðzÞ ¼ w20


z − zf
2nzR

2
þ 1

; (8)
EQ-TARGET;temp:intralink-;e009;116;75w2SðzÞ ¼ w2HðzÞ þ
1
3
ðμszÞθ2RMSðz∕nÞ2; (9)
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and z is the depth coordinate in tissue measured from the sample boundary at z0. Equation (8) is
the expression for the local beam waist in the absence of forward scattering, wH. Here, w0 is the
beam waist at the focus in air. The term θRMS is the root mean square of the average scattering
angle and related to the scattering anisotropy through θRMS ≈
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
2ð1 − gÞp . The factor of 2 in front
of the Rayleigh length of the beam is introduced to account for the doubling of the Rayleigh
length for diffuse reflection, as described earlier.30 Equation (9) is the expression for the local
beam waist in the presence of multiple forward scattering, wS.
56 Based on the EHF model, multi-
ply scattered light influences the OCT signal at all depths. Assuming highly forward scattering
media, the EHF model can be fitted to the OCT data using Eq. (7) to obtain tissue optical proper-
ties, including μs and θRMS. This is in contrast with the single-scattering formalism, which
absorbs the effects of multiple scattering in the effective attenuation coefficient μOCT.
A limitation of the EHF model is that θRMS and μs are codependent parameters, which means
that a change in θRMS can be compensated with a change in μs without any change in the out-
come of the fit statistics.30 A priori knowledge of θRMS or μs of the sample can be used to restrict
the fit.63 Alternatively, the EHF model is used with a priori knowledge of θRMS and μs for con-
trolled silica bead samples to simulate the OCT signal, in order to estimate the contribution of
multiple scattering to the single-scattering model-obtained μOCT. The model-based estimations
were in good agreement with the experimental data for a large range of scattering and anisotropy
values in silica bead samples.28,63 An absorption term was recently introduced in the EHF model
to measure not only the scattering coefficient and anisotropy but also the absorption coefficient,
which is usually assumed negligible for OCTwavelengths.64 However, further validation of such
absorption coefficient measurement is still needed.
3.2.3 Modeling of the OCT signal with Maxwell’s equations
A full-wave mathematical model of OCT image formation, based on Maxwell’s equations, has
been developed by Munro et al.57–59 Using this model, 2-D and 3-D OCT images can be simu-
lated. Compared to the above-mentioned models, the Maxwell’s equations-based model does not
need to assume the first-order Born approximation or to consider an ensemble average of the
scattering particles. This full-wave approach could, in general, allow modeling of the OCT signal
for a variety of system configurations, beam geometries (e.g., Gaussian or Bessel), and (sub-
resolution) sample parameters without making any approximations. The refractive index distri-
bution of the sample is used as an input parameter, which works well for controlled phantoms;
however, at the moment, is not generally known for biological tissue, and often not even in
statistical terms. Full-field models are very computationally expensive to run, especially for high
NAs, which limits the volume and complexity of the sample to be analyzed.58 Efficiency
improvements can be achieved by precomputing scatterer microstructure,65 and by using
analytical solutions of Maxwell’s equations for specific shapes, such as scattering from
cylinders.66,67 These models remain challenging to implement and use because of their complex-
ity and computational expense. With further development and the increase in computing power,
they offer great potential to explore the links between microscopic structure and macroscopic
parameters in quantitative imaging of tissue optics and validate the accuracy of parametric
models, such as single scattering or EHF.
3.3 Summary of Models
In summary, a variety of models for the OCT signal have been proposed in the literature, ranging
in complexity from a single exponential fit to a full-wave mathematical model based on
Maxwell’s equations. The simplest models lack consideration of system parameters and the con-
tribution of multiply scattered light. However, as models increase in complexity, more input
parameters are required. The EHF model requires codependent sample-related parameters,
which cannot be determined independently without a priori knowledge of μs or g. For
Monte-Carlo-based estimations, the same problem arises, for which the scattering phase function
has to be assumed. Although multiple models for the OCT signal have been studied in the
literature, the most frequently applied one remains the single exponential model, relying upon
the predominance of single scattering, such that the first-order Born approximation is valid.
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The single exponential model, together with accurate correction for system parameters, provides
a valid approach without the mutual dependence of the fit parameters. Alternatively, the depth-
resolved method can be applied to estimate μOCT per pixel in depth, avoiding assumptions of
tissue homogeneity in the axial direction. Although more work is undoubtedly needed to estab-
lish the level of model sophistication required, it is likely that meaningful results require one to
be in an image-forming regime, and that image formation likely requires the single scattering
assumption to be valid. Once beyond this depth, the dominance of multiple scattering may mean
that more sophisticated models do not bear fruit.
4 Applications of OCT Attenuation
OCT attenuation has been increasingly used for tissue characterization to provide additional
contrast to the OCT structural information. Methods of analysis have made use of individual
or multiple A-scans/B-scans or of volumetric scans to map the 2-D distribution of the attenuation
as en face attenuation images, as shown in Fig. 5, which, in general terms, represents a form of
parametric imaging.8,9 This section presents a survey of applications seeking to use OCT attenu-
ation to characterize tissue, with a focus on skin, arteries, and tissues with cancer, including
summarizing the characteristic attenuation coefficients of normal and diseased tissues.
Overall, the results show promising examples of contrast between normal and diseased tissue.
However, there are general issues with quantification evident in the range of experimentally
reported values, which will be discussed in Sec. 5.
4.1 Skin: Dermatological Conditions and Burns
Cutaneous tissue in humans comprises a generally thin, superficial cellular epidermis overlaying
a thicker layer of dermis containing various scatterers, including abundant collagen fibers. The
OCT attenuation in the dermis has been assessed in vivo, but there is generally limited data in
the epidermis,1 because on many parts of the body it is too thin (sub ∼100 μm for hairy skin) to
be readily amenable to measurement. Schmitt et al.1 were the first to apply an OCT-based method
(based on the single-scattering model) to measure the attenuation coefficient in normal cutaneous
dermal tissue in vivo. They performed measurements at multiple body locations on two human
subjects, including the forearm (mean μOCT: 4.6/4.7; AFR: 200 to 400 μm), finger (mean μOCT:
3.7/5.0; AFR: 250 to 500 μm), and lip (mean μOCT: 2.0 mm−1; AFR: 100 to 500 μm).
Later, Kholodnykh et al.51 studied and corrected the systematic errors in the measured attenu-
ation coefficient caused by the CPSF. They applied their method to human forearm in vivo,
reporting much higher attenuation values of dermis (μOCT: 10 to 13 mm−1; AFR: 100 μm) than
Schmitt et al. at the same mean wavelength (1300 nm). They attributed this difference to the
Fig. 5 Schematic of OCT parametric attenuation coefficient imaging. The A-scan at each lateral
location is averaged in a lateral (x–y ) window outlined by the cuboid and used to calculate the
attenuation coefficient in a depth (z) window, leading to a 2-D map in the en face (x–y ) plane.
Courtesy of Blake R. Klyen (unpublished).
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different experimental protocols, such as the pressure due to the contacting probe and the use of
clearing agent (i.e., glycerol) in Schmitt et al.’s work. These factors will be further discussed in
Sec. 5.
The single-scattering model used in these studies assumes tissue homogeneity over the depth
range (i.e., AFR) used to estimate the attenuation coefficient. However, the dermis is perfused
with a network of blood vessels with highly distinct optical properties. Experimental determi-
nation of the OCT attenuation coefficient of whole blood is challenging due to the very high
forward scattering of red blood cells.47 Bosschaart et al.68 modeled scattering properties of whole
blood using Mie theory (to describe a single blood cell) combined with the Percus–Yevick struc-
ture factor to account for nonlinear scaling of optical coefficients with volume fraction, which are
especially prevalent at high hematocrits. At 1300 nm, they found a high scattering coefficient of
35 mm−1 (close to values reported from the literature of 40 mm−1 at 1300 nm68) and a scattering
anisotropy (g) of 0.96, indicating a very high degree of forward scattering by whole blood. These
extreme values for blood compared with average values above in the 2- to 13-mm−1 range high-
light the distinct lack of homogeneity of the dermis. Additionally, many conditions are charac-
terized by visible redness of the skin, indicating higher levels of blood than in healthy skin. This
inhomogeneity leads to artifacts in the estimated attenuation coefficients when a vessel is con-
tained in the fitting window, as shown in Figs. 6(b) and 6(c). Appreciation of this issue has only
fairly recently been highlighted.35 Such artifacts may cause either underestimation or over-
estimation of the attenuation, depending on the size of the fitting window and its depth position
relative to the vessels.
To mitigate this obvious source of inhomogeneity, Gong et al. presented a method to identify
and mask the blood vessels from the attenuation estimation, using OCT speckle decorrelation for
their detection,70,71 and provided parametric imaging of the attenuation coefficient of the remain-
ing tissue.35 The resulting mean attenuation coefficient of dermis from normal human subjects
(n ¼ 6) is 6.3 0.5 mm−1 (AFR: 200 μm). Another distinction of their work is the use of a
polarization-sensitive OCT (PS-OCT) scanner to mitigate the possible errors in the quantified
attenuation coefficients due to the birefringence of dermal collagen, measured to be 0.4 to 1.3 ×
10−3 by Gong et al.72 at 1325-nm wavelength and 0.5 to 1.1 × 10−3 by Pierce et al.73 at 1300-nm
wavelength.
Using the attenuation coefficient of normal dermis as the baseline, OCT attenuation has been
applied to the assessment of cutaneous conditions, such as psoriasis, which is characterized by
Fig. 6 OCT attenuation imaging of human skin in vivo. (a) OCT vasculature image of normal skin.
(b) Parametric attenuation coefficient imaging of the tissue region in the blue square in (a). Dashed
circles outline the regions with incorrect attenuation coefficients due to the blood vessels. AFR is
200 μm with lateral averaging of 40 × 40 μm. (c) An example showing incorrect fitting caused by
vessels, from the zone marked by the lower of the purple squares in (b). (d) and (e) Longitudinal
parametric attenuation coefficient imaging of a human burn scar before and after laser treatment
with vascular masks shown in black. AFR is 250 μmwith lateral averaging of 20 × 20 μm. Adapted
from Refs. 35 and 69.
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patches of abnormal (often flaky and red) skin. Welzel et al.74 demonstrated a lower attenuation
coefficient (μOCT: 2.9 0.9 mm−1; AFR: not given; n ¼ 28) of psoriasis than in normal human
skin (μOCT: 3.6 1.5 mm−1; AFR: not given; n ¼ 28) in the upper dermis at 1300-nm wave-
length. Their longitudinal monitoring further indicated an increase of the OCT attenuation in
psoriasis after therapy (μOCT: 3.8 1.7 mm−1; AFR: not given; n ¼ 17), approaching the
measured normal skin attenuation (μOCT: 4.2 1.6 mm−1; AFR: not given). They believe these
characteristic attenuation coefficients are associated with inflammation in psoriasis, which can
impact the density and distribution of collagen fibers and, thus, the scattering properties of the
dermis. The impact of the presence of vasculature on these results is unknown.
Another example of the application of OCTattenuation measurement to cutaneous conditions
is the assessment of human burn scars. Burns arise from various causes and lead to scarring,
which presents as the proliferation of collagen and blood vessels in pathological scarring,
including hypertrophic scars and keloids. In contrast to pathological scars, normotrophic scars
present similar characteristics to the surrounding normal skin and represent the best clinical
endpoint. To investigate the optical properties of burn scars, Gong et al.35 quantified the
OCT attenuation of dermis with masking of blood vessels, providing parametric images.
They found significantly lower values (hypertrophic scar μOCT: 3.8 0.4 mm−1; normotrophic
scar μOCT: 4.2 0.9 mm−1; AFR: 200 μm) than those of the contralateral or adjacent normal
skin (μOCT: 6.3 0.5 mm−1; AFR: 200 μm; n ¼ 6), using a PS-OCT scanner. They attributed
this difference to the reduced scattering in scar tissue arising from the higher water content and
supported this assertion with corresponding optical propagation simulations showing a similar
trend.
Es’haghian et al.69 further extended vasculature-masked OCT attenuation imaging to longi-
tudinal monitoring of hypertrophic scars undergoing fractional laser ablation treatment, as shown
in Figs. 6(d) and 6(e). They reported characteristic changes in the scar attenuation after treat-
ment: an increase (31% 27%) and decrease (13% 5%) in the attenuation coefficient, respec-
tively, in immature and mature scars; there was minimal change in the higher OCT attenuation
coefficient (μOCT: 5.1 0.7 mm−1; AFR: 250 μm) of the normal untreated skin (n ¼ 7). The
difference in the average measured attenuation coefficient of normal skin from that estimated by
Gong et al.35 could be due to many factors, including intersubject variation in skin type, variation
in skin locations, the use of different AFRs and different instruments, and the use of PS-OCT.
The longitudinal measurement/imaging of OCT attenuation provides an important approach for
monitoring the tissue response to treatment. Assuming careful calibration is performed at each
time point of measurement/imaging, longitudinal imaging potentially provides a useful relative
measure of alterations over time, but more research is required to understand the meaning and
reliability of absolute attenuation coefficients of skin.
There is also preliminary use of OCT attenuation to analyze cancer tissue in skin, which will
be summarized in Sec. 4.3 on oncology.15,64 Additionally, Olsen et al.75 used OCT attenuation as
a surrogate measure of skin edema, reporting an increase of the attenuation coefficient in edema
of 10 subjects (median μOCT increased from 1.8 mm−1 at baseline to 2.3 mm−1).
Overall, the characteristic attenuation coefficients of normal skin and skin conditions
(Table 1), and their changes during treatment, indicate the great potential of OCT attenuation
for clinical monitoring of skin conditions. The reported values in Table 1 show variations among
different body locations, possibly caused by different tissue microstructures, and also for the
same body locations, such as the normal forearm skin. This might be due to the variation between
subjects and, more importantly, the inconsistency in data acquisition and processing methods.
Such variations suggest the need for a standardization of methods in future to allow better com-
parison between studies.
4.2 Cardiology
The arterial system can be affected by atherosclerosis, a systemic inflammatory disease that gives
rise to focal formations of fatty deposits in the vessel wall. This is a problem, in particular, in the
carotid and coronary arteries, where disruption of those “plaques” can trigger thromboembolism,
leading to ischemia in the brain (stroke) or heart muscle (myocardial infarction, i.e., heart attack).
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Catheter-based intravascular OCT is a powerful method for visualization of atherosclerosis and
is routinely applied in guidance of minimally invasive coronary interventions. The normal struc-
ture of healthy coronary arterial wall consists of three layers: (1) a thin, bright intimal layer;
(2) a darker medial layer with a thickness of 200 to 300 μm, consisting of smooth muscle cells
(SMCs); and (3) the connective adventitia, which has a signal-rich and heterogeneous appear-
ance on OCT. An example may be seen in Fig. 7 (top region). Atherosclerotic plaques form in the
intimal layer, which thickens under the influence of the deposition of cholesterol and related
compounds. Accumulation of these species triggers an inflammatory response, which leads
to hypoxic conditions and subsequent necrosis. Detection of these lipid-rich necrotic cores
in atherosclerotic plaque potentially enables pre-emptive interventions by medication or stenting.
Quantitative characterization of the different tissue types, including calcification and fibrous
tissues, is a potentially important application of OCT attenuation imaging.
Quantitative OCT analysis of atherosclerosis was first explored by Levitz et al.,77 who dem-
onstrated that there is quantitative OCT attenuation contrast in different ex vivo arterial tissue
components. Two studies by van der Meer et al.7,78 showed that such information could be
extracted locally and, thus, be used for differentiating tissue types. The single-scattering model
was applied to OCT data acquired from carotid arteries (n ¼ 13) ex vivo with an 800-nm time-
Table 1 Summary of published values of OCT attenuation coefficient of human dermis in vivo.
All results were calculated using single-scattering model.
Cutaneous
tissue Reference
Wavelength
(nm)
AFR
(μm)
Correction
Location Sample number
Attenuation
(mm−1)CPSF SRF
Normal
skin
Schmitt
et al.1
1300 200 to
400
Y N/A Forearm 2 subjects 4.6/4.7
(mean)
250 to
500
Finger 3.7/5.0
(mean)
100 to
500
Lip 2.0
(mean)
Kholodnykh
et al.51
1300 100 Y N/A Forearm NS 10 to 13
Gong
et al.35
1325 200 Y Y Forearm,
thigh and
lower leg
6 patients 6.3 0.5
Es’haghian
et al.69
1300 250 Y Y Upper arm,
abdomen,
back, thigh
and calf
7 patients 5.1 0.7
Welzel
et al.74
1300 NS NS NS Including
forearm
28 patients 3.6 to 4.2
(mean)
Psoriasis Welzel
et al.74
1300 NS NS NS Including
forearm
28 patients
(17 after
treatment)
2.9 0.9
(untreated)
3.8 1.7
(treated)
Burn scar Gong
et al.35
1300 200 Y Y Forearm,
thigh and
lower leg
6 patients 3.8 0.4
(hypertrophic)
4.2 0.9
(normotrophic)
Note: Papers highlighted in bold present parametric attenuation coefficient imaging; others represent point
measurements. AFR, axial fitting range; CPSF, confocal point spread function; N/A, not applicable; NS, not
specified; SRF, sensitivity roll-off function.
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domain scanner to quantify the attenuation of various tissue constituents.78 Differences between
tissue types (lipid-rich, fibrous intimal thickening, calcification, and thrombus) were attributed to
the different scatterers in these tissues, such as the highly scattering red blood cells, which lead to
a high attenuation in the thrombi. These results were extended by imaging data of atherosclerosis
with a time-domain system at a wavelength of around 1300 nm.7 They demonstrated the fea-
sibility of using OCT attenuation to differentiate tissue types. Angle dependence of scattering
parameters was investigated by Xu et al.,8 who demonstrated a strong dependence on imaging
orientation for the highly oriented SMCs in the tunica media.
Van Soest et al.16 further implemented OCT attenuation imaging of coronary arteries
(n ¼ 65) in a catheter-based OCT system, approximating in vivo clinical imaging of coronary
arteries. They demonstrated the differentiation of necrotic core and macrophage infiltration
(μOCT ≥ 10 mm−1) from calcific and fibrous arterial tissue (μOCT: 2 to 5 mm−1) using the
OCTattenuation (AFR: ≥200 μm). Ex vivo data were acquired with a time-domain OCT system.
Figure 8 shows an example of a coronary atherosclerotic lesion with a necrotic core behind
a calcified region, identified from histology [Fig. 8(b)] and marked in red in Fig. 8(c).16 The
necrotic core and calcified region exhibit similar signal strengths in the structural OCT image
in Fig. 8(a). Aided by OCTattenuation imaging in Fig. 8(d), the necrotic core is better contrasted
with the calcified region than in the original OCT image. In vivo data from this study, recorded
with a prototype swept-source OCT scanner, showed qualitatively and quantitatively similar
attenuation patterns. These results illustrate the promise of OCT attenuation to complement the
qualitative arterial tissue classification that relies on interpretation of image texture and structural
features for determination of tissue composition and plaque type. Table 2 summarizes the quan-
tified attenuation coefficients of various tissue types.
Fig. 8 OCT attenuation imaging of a coronary artery with an atherosclerotic lesion in vitro. (a) and
(b) OCT image and corresponding histology of the artery. (c) Cartoon overlaid on the histology to
indicate an advanced necrotic core (red) behind a calcification (gray), and a slight fibrotic (green)
circumferential intimal thickening. (d) OCT attenuation coefficient image ranging from 0 (blue) to
15 mm−1 (red). Scale bar: 1 mm. Adapted from Ref. 16.
Fig. 7 Schematic of the vessel wall with an advanced atherosclerotic plaque. The healthy wall
consists of three layers (top): the intima, lying directly beneath the endothelium, the media, which
consists of SMCs, and the adventitia, which is made up of connective tissues. These layers are
separated by elastic membranes (not shown). A large thin-cap fibroatheroma (bottom) is a hetero-
geneous structure that exhibits a number of characteristics that may be recognized in OCT images
and affect the attenuation coefficient. Adapted from Ref. 76.
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The attenuation coefficients vary significantly between the different studies reported in
Table 2. Qualitative identification of vascular tissue has generally followed the classification
of Yabushita et al.:79 fibrous tissue is homogeneous and signal-rich; calcified tissue is signal-
poor with well-defined borders; and lipid-rich/necrotic tissue is signal-poor with diffuse borders.
This set of criteria implicates low attenuation for both fibrous and calcified tissues, with high
backscattering for fibrous tissue and low for calcifications. Based on a tissue optics interpretation
of the qualitative classification, lipid-rich/necrotic tissue can be inferred to have strong attenu-
ation. The attenuation (and backscattering, when provided) values reported by Xu et al.,8 van
Soest et al.,16 and Liu et al.40 are consistent with this pattern; whereas, the contrast measured by
van der Meer et al.7,78 appears to be inverted. A possible explanation of this difference may lie in
the selection of fitting regions, which in the case of van der Meer et al. appears to exclude the
signal-rich proximal areas in attenuating tissues, causing them to derive data from the slowly
varying multiple-scattering background. The μOCT values for different arterial tissue types do not
significantly depend on temperature or tissue fixation, which eases the requirements on ex vivo
studies.80
Table 2 Summary of published values of OCT attenuation coefficient of arterial tissue ex vivo.
All results were calculated using single-scattering model except those by Liu et al. using the
depth-resolved method.40
Arterial tissue Reference
Wavelength
(nm)
AFR
(μm)
Correction
Location
Attenuation
(mm−1)CPSF SRF
Intimal
thickening/
fibrous
van der Meer et al.78 800 NS Y N/A Carotid 5.5 1.2
van der Meer et al.7 1300 NS Y N/A NS 3.2 1.2
Xu et al.8 1320 NS Y N/A Coronary 6.4 1.2
van Soest et al.16 1310 ≥200 Y Y Coronary 2-5
Liu et al.40 1310 N/A N N Coronary 1.8 0.5
Lipid-rich
region
van der Meer et al.78 800 NS Y N/A Carotid 3.2 1.1
van der Meer et al.7 1300 NS Y N/A NS 2.3 0.5
Xu et al.8 1320 NS Y N/A Coronary 13.7 4.5
van Soest et al.16 1310 ≥200 Y Y Coronary ≥10
Liu et al.40 1310 N/A N N Coronary 2.6 0.1
Calcification van der Meer et al.78 800 NS Y N/A Carotid 11.1 4.9
van der Meer et al.7 1300 NS Y N/A NS 26 3.2
Xu et al.8 1320 NS Y N/A Coronary 5.7 1.4
Liu et al.40 1310 N/A N N Coronary 0.9 0.2
Macrophage
infiltration
van Soest et al.16 1310 ≥200 Y Y Coronary >12
Liu et al.40 1310 N/A N N Coronary 3.4 0.4
Thrombus van der Meer et al.78 800 NS Y N/A Carotid 11.2 2.3
Kume et al.81 1300 NS N NS Coronary 3.8 1.0
(red)a
2.1 0.3
(white)a
Note: Papers highlighted in bold present parametric attenuation coefficient imaging. AFR, axial fitting range;
CPSF, confocal point spread function; N/A, not applicable; NS, not specified; SRF, sensitivity roll-off function.
aMeasured in the data presented by the authors.
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More recently, Liu et al. implemented a depth-resolved method on intravascular OCT scans
acquired in vitro on 135 images from coronary arteries on two cadaver hearts.40 Using a variety
of signal descriptors (intensity, attenuation, and backscatter), they were able to distinguish up to
six different tissue types (mixed, calcified, fibrous, lipid-rich, macrophages, and necrotic core).
Table 2 shows that the attenuation coefficient values reported by Liu et al.40 are much smaller
than those reported by other studies.8,16 Two possible causes of this discrepancy are the blind
reconstruction of amplitude (not intensity) data from 8-bit images stored on the acquisition sys-
tem, which may introduce an unknown scale factor; and the omission of correction factors for
CPSF or sensitivity roll-off. They also reported maximum and 95th percentile values for the
parameters that they computed. These quantifiers, for the top of the distribution, are in good
agreement with the values reported by Xu et al.8 and van Soest et al.16 The attenuation values
computed by the depth-resolved model are expected to be affected by OCT speckle (see Sec. 3),
but in general the effect of speckle filtering on this relation has not been studied. In the present
case, the data was filtered post-hoc by application of a median filter, but the quantitative impli-
cations of this operation are unknown.
Gnanadesigan et al.82 derived relations between μOCT and lipid-rich atherosclerotic plaque
based on optimal classification accuracy in a receiver operating characteristic analysis. They
showed that, with histology control, lipid-core plaque has μOCT > 8.5 mm−1. Thin-cap fibroa-
theroma, as identified in clinical OCT images, was found to have μOCT > 11 mm−1.
83 Their
approach to comprehensive validation of 3-D data sets, rather than matching of individual OCT
images to histology, enables statistically robust analyses with minimal operator bias.
When different arterial tissue types present similar attenuation properties, tissue characteri-
zation with OCT attenuation coefficient alone is ineffective. A combination of the OCT attenu-
ation with additional OCT-derived optical properties by Xu et al.8 and Liu et al.40 resulted in
statistically significant discrimination between tissues types. An example from Xu et al. is shown
in Fig. 9, where the calcific (red) and fibrous (green) tissues are better differentiated using the
combined attenuation and backscattering coefficient image in Fig. 9(c) than using only the
attenuation in Fig. 9(b). Such combination of multiple parameters provides one promising
approach to enhance tissue contrast and, thus, may provide better tissue classification for future
applications, if they can be reliably extracted from catheter-based measurements.
4.3 Oncology
Another promising application of OCT attenuation imaging is in the characterization of cancer.
Expected changes in tissue caused by cancer, relevant to OCT, include altered cellular arrange-
ment; density and size of nuclei and organelles; proliferation and changes in the organization
of the extracellular matrix; and changes in the blood and lymphatic microvasculature.84,85
McLaughlin et al.9 were the first to apply parametric OCT attenuation imaging to assess cancer
ex vivo, extracting an attenuation coefficient for each A-scan and visualizing the spatially dis-
tributed attenuation values as an en face image (Fig. 10). Although they quantified only the
Fig. 9 Combined imaging of OCT attenuation and backscattering coefficient of a fibrocalcific
plaque. (a) and (b) Images of histology and OCT attenuation coefficient. (c) Image of the combined
attenuation and backscattering coefficient using the colormap in (d). C, calcific tissue; F, fibrous
tissue; L, lipid tissue. The three tissue types led, respectively, to attenuation coefficients of
5.7 1.4 mm−1, 6.4 1.2 mm−1, and 13.7 4.5 mm−1; and backscattering coefficients of
4.9 1.5 mm−1, 18.6 6.4 mm−1, and 28.2 8.9 mm−1, respectively. Adapted from Ref. 8.
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relative values of attenuation coefficient, the demonstration on malignant human axillary lymph
nodes from breast cancer patients (n ¼ 2) indicated the presence of contrast between malignant
and healthy non-neoplastic tissue. Figure 10 shows one such example indicating the differen-
tiation of residual healthy tissue (circled regions) in a malignant lymph node as the low attenu-
ation coefficient regions in Fig. 10(b), which is difficult to identify using the original OCT image
in Fig. 10(c). This contrast was attributed to the changes in size and texture of cell nuclei result-
ing from the neoplastic transformation.86 Their method was further developed and applied by
Scolaro et al.17 for imaging the absolute attenuation coefficients in axillary lymph nodes (n ¼ 4).
They summarized the OCT attenuation coefficients of various tissue subtypes, as included in
Table 3, to guide the classification of different tissue types within the lymph node. A strikingly
attractive feature of the results of that work is the relative lack of overlap between tissue types
and attenuation coefficient values—a fact that would need further testing given the small sam-
ple size.
OCT attenuation has also been used to characterize ovarian cancer, which is difficult to diag-
nose at an early stage due to the lack of symptoms, resulting in the lowest survival rate of the
gynecologic cancers. Yang et al.13 applied OCT attenuation to ovaries (n ¼ 18) ex vivo, showing
lower attenuation values in malignant tissue (μOCT: 1.6 0.5 mm−1) than in normal tissue (μOCT:
2.4 0.6 mm−1). In a subsequent study, they demonstrated consistent contrast between the
malignant (μOCT: 1.7 0.6 mm−1) and normal tissue (μOCT: 2.4 0.7 mm−1) in ovaries (nor-
mal: n ¼ 26; malignant: n ¼ 7),87 and further augmented the attenuation with measurement of
the cumulative phase retardation caused by the birefringence of collagen tissue. The combination
of these two parameters shows high sensitivity and specificity for the classification of malignant
and normal ovary tissue. They further explained the influence of the measured collagen area
fraction lower in the malignant than in the normal tissue on the contribution of the collagen
tissue to the two quantified optical properties.
Analysis of urothelial carcinoma (UC) by OCT attenuation has also been investigated.
Cauberg et al.18 measured OCT attenuation in human bladder samples (n ¼ 54) to assist grading
of UC tissue ex vivo. They reported the attenuation coefficients (overspecified to two decimal
places) for different tissues, including benign tissue (median μOCT: 5.75 mm−1); and grade 1
(median μOCT: 5.52 mm−1), 2 (median μOCT: 4.85 mm−1), and 3 (median μOCT: 5.62 mm−1)
UC at 850-nm wavelength. Bus et al.3 extended this analysis to patients (n ¼ 7) in vivo and
reported the higher attenuation in grade 3 (median μOCT: 3.53 mm−1) than 2 (median μOCT:
1.97 mm−1) lesions. A follow-on study on a large number of patients (n ¼ 26) by Bus et al.
further validated the higher attenuation of high-grade lesions (median μOCT: 3.0 mm−1) than
low-grade lesions (median μOCT: 2.1 mm−1), demonstrating the feasibility of OCT attenuation
for grading low- and high-grade lesions.88 A recent study on 35 patients by Freund et al.89 dem-
onstrated a consistent contrast in OCT attenuation, as summarized in Table 3.
OCT attenuation has also been applied to investigate other types of cancer. For example,
Muller et al.90 used OCT attenuation to aid in the characterization of prostate cancer, reporting
attenuation coefficients of benign (mean μOCT: 3.8 mm−1; AFR: 500 μm) and malignant (mean
μOCT: 4.1 mm−1; AFR: 500 μm) tissue. They noted that not all tissue with high attenuation coef-
ficient corresponded to cancer. Buijs et al.91 explored the use of OCT attenuation to assist the
Fig. 10 OCT attenuation imaging of a malignant human axillary lymph node. (a)–(c) Histology,
OCT attenuation, and structural OCT image of the lymph node. The circles highlight the residual,
noncancerous cortical tissue. Scale bars: 1 mm. Adapted from Ref. 9.
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differentiation of renal cell carcinoma (median μOCT: 4.3 mm−1), respectively, versus benign
renal masses (median μOCT: 3.2 mm−1) and versus oncocytomas (median μOCT: 3.4 mm−1),
based on 95 patients. The results showed the improved diagnostic yield aided by OCT
attenuation.91 Kut et al.92 investigated the OCT attenuation of cancerous and noncancerous brain
tissue from human patients (n ¼ 37) and reported lower attenuation coefficients in cancerous
tissue (infiltrated zone mean μOCT: 3.5 and 2.7 mm−1, cancer core mean μOCT: 3.9 and
4.0 mm−1, respectively, for high-grade and low-grade) than in noncancerous white matter tissue
(mean μOCT: 6.2 mm−1). They attributed this contrast to the invading cancer cells, which break
down and decrease the expression of myelin in white matter. Similar contrast was recently
reported by Almasian et al.93 from an in vivo study, as summarized in Table 3. A recent study
on ex vivo human brain tissue by Yashin et al.94 reported consistently lower attenuation coef-
ficients of the tumorous tissue than the normal tissue. In addition, they observed a significant
influence of tumor necrosis on the measured attenuation coefficients. Wessels et al.15 applied
OCT attenuation analysis to vulvar intraepithelial neoplasia (VIN), which can progress to vulvar
squamous cell carcinoma. The results showed higher attenuation coefficients in VIN (μOCT:
6.2 2.1 mm−1) than in healthy skin (μOCT: 2.1 1.4 mm−1). They also investigated cutaneous
melanoma and reported lower attenuation in melanomas (mean μOCT: 4.3 mm−1) than in benign
lesions (mean μOCT: 5.5 mm−1).
14 The results in these various pilot studies indicate the general
promise of OCT attenuation as a biomarker to characterize cancer.
4.4 Other Tissues
Building on from the wide application of OCT to ophthalmology, OCT attenuation analysis has
been explored to investigate eye diseases in vivo, such as glaucoma. The OCT attenuation in the
retinal nerve fiber layer (RNFL) of healthy (n ¼ 10with an RNFL thickness ∼50 to 220 μm) and
glaucomatous subjects (n ¼ 30) has been analyzed by van der Schoot et al.,100 showing decreas-
ing values with severity in glaucoma (overspecified to 2 decimal places): (mild glaucoma μOCT:
4.09 0.34 mm−1; moderate glaucoma μOCT: 3.14 0.22 mm−1; and advanced glaucoma
μOCT: 2.93 0.33 mm−1), as compared to normal subjects (μOCT: 4.78 0.46 mm−1).
Consistent contrast was later presented by Vermeer et al. in a study on healthy (n ¼ 10) and
glaucomatous (n ¼ 8) eyes.101 They explained this contrast as due to the decreased density
of nerve fibers in glaucoma. Additionally, the OCT attenuation coefficients of the multiple tissue
layers (including the RNFL) in the retina have been extracted by DeBuc et al.102 and Sun et al.103
to assess other diseases that cause changes in the retina, including diabetes and pituitary
adenoma. However, despite the promise, larger sample sizes are needed to establish the feasibil-
ity of OCT attenuation for assessing these diseases.
In additional, OCTattenuation has been applied to the characterization of various other tissue
pathologies, such as parametric imaging of dystrophic muscle tissue, to identify necrotic lesions
in mouse models of muscular dystrophy (necrotic lesion μOCT: 9.6 0.3 mm−1 and necrotic
myofiber μOCT: 7.0 0.6 mm−1 versus healthy tissue μOCT: 3.9 0.2 mm−1; AFR: 500 μm),104
and measurement of cartilage tissue to quantify differences between the healthy cartilage (μOCT:
9.7 3.3 mm−1), repaired tissue (μOCT: 3.1 1.4 mm−1), and bone (μOCT: 4.5 0.5 mm−1) in
goats with induced osteochondral defects.105 All of these studies on OCT attenuation, both at
the level of initial demonstration and relatively large-scale clinical data sets, have shown good
potential for improved quantitative tissue characterization as compared to the use of only the
qualitative OCT images.
5 Discussion
5.1 Measurement Variation, Accuracy, and Precision
The use of OCTattenuation for tissue characterization and differentiation is gradually expanding,
and promising examples of contrast between normal and diseased tissue have been shown.9,13–19
However, there are overall large variations in the attenuation values of the same tissue types
across studies, as summarized in Sec. 4. There are general issues with OCT attenuation
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measurement, making it challenging to fully understand the origins of such large variations.
These issues include the lack of clarity of the instrument configuration, data processing method,
depth range for attenuation calculation, accuracy, and precision (e.g., attenuation coefficients
presented with too many significant figures), and inconsistency in how the values are reported
(median versus mean versus value range). Therefore, we urge authors of future studies to clearly
specify the details of the implementation of OCT attenuation calculations to provide improved
clarity and consistency, including at least the following.
1. Instrument and measurement configuration: OCT scanner type, wavelength, imaging
resolutions (axial, including assumptions on refractive index, and lateral), sampling den-
sity, use of polarization diversity detection, and contact/noncontact scanning mode.
2. Data processing key parameter and method: OCT model, preprocessing (e.g., averag-
ing and tissue surface detection), correction for CPSF and sensitivity roll-off, axial range
for fitting/calculation, fitting/calculation method and assessment of fit quality, masking of
vessels for in vivo scans and processing time.
3. Sample handling and results presentation: provide assessment of measurement accu-
racy and precision, report the attenuation coefficient range, mean, median, and variation,
and specify the number of samples and measurements within samples, tissue locations,
and tissue processing if any (e.g., time from harvesting, freezing, optical clearing and
fixing/histological tissue processing).
Reporting the above will improve the comparability, and ultimately reproducibility, of results
across laboratories and enable understanding of the current variations as well as point to
solutions.
The accuracy and precision of OCTattenuation measurement have not been comprehensively
investigated in most studies, which in part have contributed to the large variations. To date, the
most practical approach to assess the accuracy and precision is using a homogeneous imaging
phantom with well controlled and known optical properties, such as polystyrene microsphere or
silica bead solutions. The theoretical attenuation coefficients are estimated using a scattering
model, such as Mie theory, for a set of phantoms with varying concentrations (or even sizes)
of scatterers and, thus, varying attenuations. The measured OCTattenuation of the phantoms can
then be compared to the theoretical values, building a calibration curve for estimating the accu-
racy and precision, as performed by Almasian et al.28
One issue with this approach is the reduced accuracy when the concentrations of the
scatterers are sufficiently high,28 for appreciable “multiparticle scattering” (i.e., interferences
between the densely distributed scatterers) to occur.106 To mitigate this, the estimation of the
theoretical attenuation coefficient with discrete particle models must be augmented to take into
account such effects. In addition, the approach involves the preparation of multiple solutions of
scatterers, which is tedious but feasible. A solid phantom with structured attenuation (e.g., an
array of thin pillars filled with medium with varying attenuations) is highly desirable and can be
feasible based upon progress in imaging phantom fabrication achieved to date.107,108 Such a
phantom could then be replicated and be readily applied in multiple studies for multi-laboratory
validation, which would provide an important assessment of measurement accuracy and preci-
sion and help understand and minimize the large variations that currently exist. In addition, it is
also possible to assess the accuracy and precision by comparing OCT attenuation to other meth-
ods for measuring tissue optical properties, such as measurement of light transmittance through
the sample,109 but this approach has not been explored so far.
5.2 Tissue Heterogeneity
Biological tissue typically presents heterogeneity along both the axial and lateral directions in the
OCT imaging volume. The lateral heterogeneity in tissue is less problematic than the axial
heterogeneity, and in fact favorable when parametric imaging of the tissue attenuation is
required. The axial heterogeneity complicates OCT attenuation measurement in particular as
one crucial assumption in the OCT models is homogeneity over the depth range used in the
calculation.
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Image segmentation, thus, forms an important part of an automated workflow for OCT
attenuation analysis, so as to restrict the depth range for calculation to relatively homogeneous
tissue regions. The first step in such segmentation is detecting the tissue surface, which can avoid
artificial nonphysical negative attenuation resulting from the inclusion of noise signal above the
tissue surface, as highlighted by Yuan et al.36 There are multiple methods available for surface
detection, mainly using the markedly strong reflectance and correspondingly high OCT signal at
the tissue surface. These methods include the use of the local maximum OCT signal intensity,
local maximum gradient of the OCT signal, and the Canny edge detector.70,110–112 The under-
lying tissue may present different morphologies and need further segmentation, especially when
the tissue presents layered structures with varying OCT signal strength. For example, normal
skin comprises epidermis (low signal) and dermis (high signal), and normal coronary arterial
wall comprises intima (high signal), media (low signal), and adventitia (high signal), which
are further segmented to confine the depth ranges for attenuation measurement.112,113 Overall,
the capacity to locate homogeneous tissue regions for attenuation calculation is dependent on
the specific tissue morphology and the corresponding contrast in OCT signal and may need
additional revision of the methods under specific disease conditions. Such revisions will be
disease- and tissue-dependent and may not be feasible for all conditions.
The impact of axial tissue heterogeneity can also be mitigated by data processing methods in
the single-scattering model, using the depth-resolved method or an adaptive window fitting
approach. The depth-resolved method calculates the attenuation coefficient for each tissue depth
(local attenuation coefficient) and does not require tissue homogeneity on the scale (100 to
500 μm) required by the fitting method.38 However, as it assumes the full attenuation of light
in each A-scan, the obtained attenuation coefficients are sensitive to the estimation of the noise
level and, thereby, likely to be less reliable in cases where contributions from multiple scattering
are significant. Additionally, the correction of system-dependent functions (i.e., CPSF and sen-
sitivity roll-off) and noise in this approach have not yet been fully described.41 As well, it is not
yet clear how to assess the accuracy of the volumetric attenuation coefficients obtained using this
method. Further research is still needed to address these issues. On the other hand, adaptive
window fitting extends the model fitting to variable depth ranges in each A-scan, by tuning the
length of the fitting window from a fixed start depth or the depth of the window with fixed length,
to generate parametric volumes.16,17 In these implementations, the goodness of fit is calculated
for each fitting and used to select the optimal fitting range and the resulting attenuation coef-
ficient. One disadvantage is the significantly longer computation time due to the increased num-
ber of fits performed. Care should also be taken to validate if the optimal fitting leads to a
physically reasonable attenuation coefficient. Apparently good fitting may sometimes lead to
an artificial nonphysical negative attenuation coefficient when the fitting extends from a locally
low signal region to a deeper region with high signal.
Speckle averaging provides an important method to mitigate the impact of the local hetero-
geneity and the inherent speckles on attenuation measurement. Even in homogeneous samples,
the presence of OCT speckles requires the use of averaging in the axial and/or lateral directions
to provide reliable attenuation estimation. Although speckle averaging/reduction is an active
field of research,114 there is a need for further study to assess the impacts of the methods and
degree of averaging on the estimated attenuation coefficients and to suggest optimal averaging.
One ubiquitous source of tissue heterogeneity in living tissue is the microvascular network,
comprising blood and lymphatic vessels.115 Each type of vessel presents very different scattering
properties to those of the surrounding tissue, creating local heterogeneity in the OCT signal that
has rarely been taken into account. The blood vessels present very high levels of scattering,
which at the OCT wavelengths is strongly forward directed due to the large, high-contrast scat-
terers (mainly red blood cells).116 This contrast leads to lower OCT signals in vessel regions
than in the surrounding tissue and artifacts in the estimated attenuation coefficients when the
calculation window covers the vessel pixels, as demonstrated by Gong et al.35 The lymphatic
vessels have been observed first by Vakoc et al.115 to present even lower signals than the blood
vessels, almost approaching the OCT noise floor, due to the transparency (i.e., absence of
scatterers) of the lymph.117–119 This transparency, which has also been observed in nerve
fibers,120 can lead to similar artifacts in attenuation analysis. One approach to eliminate such
artifacts is segmenting the vessels with OCT angiography and/or lymphangiography, and
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masking them to restrict the attenuation analysis to A-scans without vessels.35 In addition, such
implementation can also provide a more comprehensive tissue characterization, namely using
OCT attenuation and vascular imaging to assess the avascular tissue components and the micro-
vascular network, respectively.
5.3 Other Factors Affecting Measurement
Multiple additional factors can impact the measurement of OCT attenuation, including the pres-
sure induced by contact scanning, tissue birefringence, and the use of optical clearing agents.
Contact scanning mode is used either intentionally, such as for skin imaging to mitigate motion
artifact, or unintentionally in intravascular imaging due to the uncontrolled positioning of the
imaging catheter inside the vessels. It is well known that compression of a sample induces more
scattering. This phenomenon is largely the simple consequence of increasing the gradient of the
refractive index by reducing the axial dimensions between scatterers. This pressure-enhanced
scattering is captured by the OCT signal and can then alter the measured attenuation, but its
quantitative effect on the OCT attenuation coefficient has not been studied. Interestingly,
Kholodnykh et al.51 reported approximately twice the OCT attenuation value of that measured
by Schmitt et al.1 from human forearm skin at the same OCT wavelength (1300 nm) and attrib-
uted this difference, in part, to the pressure resulting from the contacting probe. As a comparison,
the pressure-induced changes to the reduced scattering coefficient have been extensively studied
in fiber-probe-based diffuse reflectance spectroscopy. For example, Reif et al.121 reported an
increase of the reduced scattering coefficient at 700 nm with the increasing pressure, which was
attributed to the increased density of the scatterers, although there are also inconsistent results in
the field.122 Quantification of the impacts of pressure on OCT attenuation is still needed, and the
use of contact scanning needs to be clarified in future studies.
Many tissues are birefringent due to the presence of long thin fibrous structures, such as
the abundant collagen fibers in dermal skin with locally or globally unidirectional arrangement.
The interactions of birefringent tissue with OCT light leads not only to attenuation but also to
variation in the polarization state of light with tissue depth.123 An attenuation measurement of
a birefringent sample with a conventional OCT system can be problematic, as the detected OCT
reflectance signal strength depends not only on the tissue attenuation but also on the polarization
state of the incident light, the OCT components that can alter the light polarization, and the
birefringence of the tissue sample. For example, the logarithmic OCT structural B-scans of bire-
fringent samples can show a banding-like pattern versus depth in tissue, which modulates the
exponential decay expected in the single-scattering model for homogeneous tissue regions. Such
dependence of the OCT signal on the tissue birefringence will then lead to inaccuracy of the
estimated attenuation coefficients. Simultaneous detection of the OCT signal in two orthogonal
polarization channels can eliminate such polarization artifacts.
Optical clearing is a widely studied method of introducing an agent to make tissue more
transparent to allow greater light penetration and provide consequently deeper imaging.124
The scattering in tissue originates from gradients caused by mismatches in the refractive index
of scatterers. The main contributors to the gradients, as modeled by Schmitt and Kumar,125
include tissue fibers (bundles of elastin and collagen), cytoplasmic organelles (e.g., mitochon-
dria), and cell nuclei, in contrast to the cytoplasm and interstitial fluid with lower refractive
index. Optical clearing agents are thought to penetrate into extracellular spaces and reduce the
mismatch in refractive index. This then leads to reduced scattering (i.e., elevated tissue trans-
parency) and enhanced imaging depth in tissue.124 As a result, optical clearing has been shown
to reduce attenuation coefficients in the OCT signal. For example, Deng et al.126 investigated
OCT attenuation of rat skin in vivo following the application of polyethylene glycol with a pen-
etration enhancer. They reported a decrease of the attenuation from 7.0 to 4.9 mm−1 at 120 min
after the application of glycerol. Genina et al.127 reported a decrease of OCT attenuation by
values in the range 16% to 32% for different optical clearing agents applied to rat dermis.
Measurement of the OCT attenuation provides a method to assess the optical clearing
effects.126,127 Notwithstanding its long gestation, further work is needed to understand the utility
of optical clearing in practical applications.
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5.4 Complementary Optical Properties
To enhance the contrast for tissue characterization and differentiation, additional optical proper-
ties can be obtained from the OCT signal to supplement attenuation, such as the backscattering
coefficient (μb;NA) (or local reflectance used by Levitz et al.
54). The backscattering coefficient of
the sample, detected within the NA of the OCT system, has been extracted from the OCT ampli-
tude after correcting for system parameters.8,28,54,128–131 Xu et al.8 and Liu et al.,40 respectively,
added the backscattering coefficient and backscatter term (linearly related to the logarithm of
the backscatter coefficient) to the attenuation coefficient, providing an approach to further differ-
entiate atherosclerotic tissue components with similar attenuation coefficients.
The simultaneous measurement of attenuation and backscattering coefficients also allows the
extraction of further parameters, including the anisotropy and the size of the scatterers. Kodach
et al.128 calculated the ratio of backscattering coefficient to the total scattering coefficient
(extracted from the OCT signal) as the phase function integrated over the NA (pNA). They then
built two calibration functions, including pNA versus particle diameter and anisotropy versus
particle diameter, aided by Mie theory. The OCT-estimated pNA of an Intralipid sample was
input into the pNA versus particle diameter function to decide the scatterer size, which was fur-
ther input into the anisotropy versus particle diameter function to decide the anisotropy. A similar
approach has been used by Schneider et al.129 for measuring the size of dispersed polystyrene
nanoparticles. Levitz et al.54,130 proposed the simultaneous calculation of attenuation and local
reflectance, which were then fed into the calibration grid in the attenuation–local reflectance
map to extract the anisotropy of developing collagen gels. To our knowledge, these methods
for estimating the scatterer anisotropy and size have not yet been demonstrated on biological
samples.
As described above, PS-OCT detects the polarization states of the reflected OCT light, aided
by polarization diversity detection.123 Estimation of the birefringence and related polarization
parameters (e.g., degree of polarization uniformity and optic axis orientation) represents an inter-
esting alternative form of parametric imaging both with versions that integrate over similar axial
regions as OCT attenuation imaging72,132 and local versions.133,134 Finally, retrieval of diatten-
uation—the polarization state-dependent differential attenuation—is also possible via PS-OCT
but to the authors’ knowledge is thought to be a small effect and has not yet been widely
investigated.135,136 Also based on polarization detection, Yashin et al.94 recently used cross-
polarization OCT to simultaneously measure the attenuation coefficients of the co- and cross-
polarized detected light. Demonstrations on human and rat brain tissues have indicated the
potential for differentiation of cancer and normal tissue.94,137
We finally observe that, as well as optical properties, parametric OCT imaging can also be
used to observe mechanical properties of tissue.138,139 All such properties, optical and otherwise,
show great potential to be combined with OCT attenuation imaging to provide a more compre-
hensive assessment of tissues.
6 Conclusion
For more than 25 years, OCT has been studied and used as a tool for characterizing morphology
on the 1- to 15-μm resolution scale. At the same time, it is widely accepted that submicrometer
microscopic changes in tissue structure and organization due to disease progression causes
altered tissue optical properties, which can possibly be probed by the OCT attenuation coeffi-
cient. Multiple models have been advanced to obtain the attenuation coefficient, ranging in
sophistication, but by far the most commonly used model is the single-scattering model, which
is used in almost all studies on clinically relevant tissues reported in this review. Our overview of
these studies highlights the generally small sample sizes both on ex vivo and in vivo samples.
The reported values of the OCT attenuation coefficient suggest that, although most pathologies
show a change in μOCT, the difference between normal and diseased tissue is not always
significant. In some studies, relative μOCT values alone are sufficient, whereas other studies show
the effectiveness of combining μOCT with other OCT-derived parameters in differentiating
healthy and diseased tissues. Our overview also highlights the wide spread in reported μOCT
values, which results from the use of different systems, methodologies, and sample preparation,
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as well as on occasions a lack of rigor in approach. Thus, whilst we remain optimistic overall,
efforts toward standardization on a rigorous methodology in future research are crucial to
advancing this field.
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